You can find the annual or quarterly income statement of Jasper Therapeutics Inc here for insights into the performance and operational efficiency of Jasper Therapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

Operating expenses

-49.77%10.95M

-41.71%14.74M

-3.64%19.17M

69.30%27.08M

44.65%21.80M

42.65%25.29M

2.72%19.89M

-10.29%15.99M

8.07%15.07M

28.94%17.73M

52.36%19.36M

49.02%17.83M

9.15%13.95M

13.78%13.75M

26.08%12.71M

42.11%11.96M

104.32%12.78M

102.79%12.08M

67.76%10.08M

--8.42M

--6.25M

--5.96M

--6.01M

R&D expenses

-64.02%5.81M

-46.59%10.56M

-0.44%14.39M

87.64%21.20M

56.89%16.16M

42.91%19.77M

-2.65%14.46M

-15.05%11.30M

5.03%10.30M

49.05%13.84M

64.58%14.85M

63.45%13.30M

19.75%9.80M

7.22%9.28M

25.51%9.02M

57.78%8.13M

85.25%8.19M

86.29%8.66M

59.03%7.19M

--5.16M

--4.42M

--4.65M

--4.52M

Depreciation, depletion, and amortization

-93.00%21.00K

0.00%300.00K

-57.67%229.00K

0.00%300.00K

6.01%300.00K

96.01%541.00K

9.09%300.00K

9.49%300.00K

-5.67%283.00K

-8.00%276.00K

26.15%275.00K

26.85%274.00K

38.25%300.00K

127.27%300.00K

651.72%218.00K

881.82%216.00K

--217.00K

--132.00K

--29.00K

--22.00K

--0.00

Operating profit

49.77%-10.95M

41.71%-14.74M

3.64%-19.17M

-69.30%-27.08M

-44.65%-21.80M

-42.65%-25.29M

-2.72%-19.89M

10.29%-15.99M

-8.07%-15.07M

-28.94%-17.73M

-52.36%-19.36M

-49.02%-17.83M

-9.15%-13.95M

-13.78%-13.75M

-26.08%-12.71M

-42.11%-11.96M

-104.32%-12.78M

-102.79%-12.08M

-67.76%-10.08M

---8.42M

---6.25M

---5.96M

---6.01M

Net non-operating interest income (expenses)

Non-operating interest income

-73.72%164.00K

-63.97%338.00K

-73.36%342.00K

-69.86%437.00K

-54.98%624.00K

-23.99%938.00K

-10.40%1.28M

0.97%1.45M

26.46%1.39M

--1.23M

--1.43M

--1.44M

--1.10M

----

Special income (expenses)

--9.64M

--5.33M

10395.00%2.10M

----

-94.01%20.00K

----

98.51%-20.00K

-88.09%28.00K

-42.11%334.00K

-71.43%420.00K

-112.58%-1.34M

-92.42%235.00K

-91.36%577.00K

--1.47M

404.00%10.64M

177.31%3.10M

241.86%6.68M

--0.00

---3.50M

---4.01M

---4.71M

Other non-operating income (expenses)

58.73%-26.00K

-211.54%-29.00K

-3767.31%-2.01M

-110.00%-84.00K

-186.36%-63.00K

122.03%26.00K

-201.96%-52.00K

63.30%-40.00K

68.57%-22.00K

-139.20%-118.00K

-80.97%51.00K

-222.47%-109.00K

2.78%-70.00K

476.25%301.00K

--268.00K

9000.00%89.00K

-7300.00%-72.00K

---80.00K

----

---1.00K

--1.00K

----

Income before tax

94.47%-1.17M

62.58%-9.10M

-0.53%-18.74M

-83.25%-26.72M

-54.73%-21.24M

-46.68%-24.32M

-6.23%-18.64M

9.31%-14.58M

3.73%-13.73M

-25.51%-16.58M

-47.89%-17.54M

-54.56%-16.08M

-546.13%-14.26M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.40M

77.37%-2.21M

9.31%-9.06M

68.48%-3.41M

---8.41M

---9.75M

---9.99M

---10.82M

Income after tax

94.47%-1.17M

62.58%-9.10M

-0.53%-18.74M

-83.25%-26.72M

-54.73%-21.24M

-46.68%-24.32M

-6.23%-18.64M

9.31%-14.58M

3.73%-13.73M

-25.51%-16.58M

-47.89%-17.54M

-54.56%-16.08M

-546.13%-14.26M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.40M

77.37%-2.21M

9.31%-9.06M

68.48%-3.41M

---8.41M

---9.75M

---9.99M

---10.82M

Net income from continuous operations

94.47%-1.17M

62.58%-9.10M

-0.53%-18.74M

-83.25%-26.72M

-54.73%-21.24M

-46.68%-24.32M

-6.23%-18.64M

9.31%-14.58M

3.73%-13.73M

-25.51%-16.58M

-47.89%-17.54M

-54.56%-16.08M

-546.13%-14.26M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.40M

77.37%-2.21M

9.31%-9.06M

68.48%-3.41M

---8.41M

---9.75M

---9.99M

---10.82M

Net income attributable to controlling interests

94.47%-1.17M

62.58%-9.10M

-0.53%-18.74M

-83.25%-26.72M

-54.73%-21.24M

-46.68%-24.32M

-6.23%-18.64M

9.31%-14.58M

3.73%-13.73M

-25.51%-16.58M

-47.89%-17.54M

-54.56%-16.08M

-546.13%-14.26M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.40M

77.37%-2.21M

9.31%-9.06M

68.48%-3.41M

---8.41M

---9.75M

---9.99M

---10.82M

Net income attributable to common shareholders

94.47%-1.17M

62.58%-9.10M

-0.53%-18.74M

-83.25%-26.72M

-54.73%-21.24M

-46.68%-24.32M

-6.23%-18.64M

9.31%-14.58M

3.73%-13.73M

-25.51%-16.58M

-47.89%-17.54M

-54.56%-16.08M

-546.13%-14.26M

-45.87%-13.21M

-247.68%-11.86M

-23.65%-10.40M

77.37%-2.21M

9.31%-9.06M

68.48%-3.41M

---8.41M

---9.75M

---9.99M

---10.82M

Basic earnings per share

97.10%-0.04

80.47%-0.32

9.35%-1.13

-79.09%-1.74

-37.35%-1.41

-7.98%-1.62

22.30%-1.24

33.91%-0.97

36.35%-1.03

58.37%-1.50

50.71%-1.60

48.49%-1.47

-166.12%-1.62

-51.10%-3.60

-259.56%-3.24

-28.47%-2.86

76.44%-0.61

9.68%-2.39

68.48%-0.90

---2.23

---2.58

---2.64

---2.86

Diluted earnings per share

97.10%-0.04

80.47%-0.32

9.35%-1.13

-79.09%-1.74

-37.35%-1.41

-7.98%-1.62

22.30%-1.24

33.91%-0.97

36.35%-1.03

58.37%-1.50

50.71%-1.60

48.49%-1.47

-166.12%-1.62

-51.10%-3.60

-259.56%-3.24

-28.47%-2.86

76.44%-0.61

9.68%-2.39

68.48%-0.90

---2.23

---2.58

---2.64

---2.86

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

